Authors: Zuniga, J Vargas-Alarcon, G Salgado, N Flores, C Martinez-Tripp, S Miranda, A Balbuena, A Osnaya, N Juarez, F Granados, J Reyes-Teran, G

Citation: J. Zuniga et al., Determinant genetic factors of resistance to HIV infection and control of AIDS progression: Implications about pathogenesis and therapeutic strategies for HIV eradication - Genetic factors in HIV infection, REV INV CLI, 52(3), 2000, pp. 284-295

Authors: Ramirez-Amador, VA Esquivel-Pedraza, L Ponce-de-Leon, S Reyes-Teran, G Gonzalez-Guevara, M Ponce-de-Leon, S Sierra-Madero, JG

Citation: Va. Ramirez-amador et al., Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: A double-blind placebo-controlled clinical trial, CLIN INF D, 28(4), 1999, pp. 892-894

Authors: Locher, CP Grant, RM Collisson, EA Reyes-Teran, G Elbeik, T Kahn, JO Levy, JA

Citation: Cp. Locher et al., Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination, AIDS RES H, 15(18), 1999, pp. 1685-1689

Authors: Mourich, DV Lee, S Reyes-Teran, G Mackewicz, CE Levy, JA

Citation: Dv. Mourich et al., Lack of differences in nef alleles among HIV-infected asymptomatic long-term survivors and those who progressed to disease, AIDS RES H, 15(17), 1999, pp. 1573-1575